1.40
price down icon3.45%   -0.05
pre-market  Pre-mercato:  1.40  
loading
Precedente Chiudi:
$1.45
Aprire:
$1.46
Volume 24 ore:
60,347
Relative Volume:
0.20
Capitalizzazione di mercato:
$3.86M
Reddito:
-
Utile/perdita netta:
$-23.42M
Rapporto P/E:
-0.0179
EPS:
-78
Flusso di cassa netto:
$-16.67M
1 W Prestazione:
-9.68%
1M Prestazione:
-46.97%
6M Prestazione:
-89.63%
1 anno Prestazione:
-97.11%
Intervallo 1D:
Value
$1.35
$1.5475
Intervallo di 1 settimana:
Value
$1.35
$1.6003
Portata 52W:
Value
$1.35
$67.00

Mustang Bio Inc Stock (MBIO) Company Profile

Name
Nome
Mustang Bio Inc
Name
Telefono
(781) 652-4500
Name
Indirizzo
377 PLANTATION STREET, WORCESTER, NY
Name
Dipendente
80
Name
Cinguettio
@Mustang_Bio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
MBIO's Discussions on Twitter

Confronta MBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MBIO
Mustang Bio Inc
1.40 3.86M 0 -23.42M -16.67M -78.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-05-18 Iniziato BTIG Research Buy
2020-10-02 Iniziato B. Riley FBR Buy
2019-11-20 Iniziato Cantor Fitzgerald Overweight
2019-08-13 Iniziato H.C. Wainwright Buy
2019-06-21 Iniziato Cantor Fitzgerald Overweight
2017-12-21 Iniziato Oppenheimer Outperform
Mostra tutto

Mustang Bio Inc Borsa (MBIO) Ultime notizie

pulisher
Mar 11, 2025

Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR

Mar 11, 2025
pulisher
Mar 10, 2025

Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India

Mar 10, 2025
pulisher
Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025
pulisher
Mar 05, 2025

Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

Mustang Bio Overcomes Delisting Threat: What This Nasdaq Compliance Means for Investors - StockTitan

Mar 05, 2025
pulisher
Mar 03, 2025

BRIEF—Mustang Bio sells assets; focuses on MB-109, MB-108 and MB-101 - The Pharma Letter

Mar 03, 2025
pulisher
Mar 03, 2025

Mustang Bio (MBIO) Projected to Post Earnings on Monday - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Mustang Bio stock plunges 29% on lease termination news - MSN

Mar 02, 2025
pulisher
Mar 02, 2025

Mustang Bio stock plunges to 52-week low at $2 By Investing.com - Investing.com Australia

Mar 02, 2025
pulisher
Feb 28, 2025

Mustang Bio stock plunges to 52-week low at $2 - Investing.com

Feb 28, 2025
pulisher
Feb 27, 2025

Mustang Bio exits Worcester facility, sells assets to AbbVie By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio stock plunges 29% on lease termination news (MBIO:NASDAQ) - Seeking Alpha

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio exits lease for Massachusetts facility, divests equipment - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility -February 27, 2025 at 05:49 pm EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio exits Worcester facility, sells assets to AbbVie - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

Can Mustang Bio's $3M Financial Boost From Facility Exit Revitalize Its Cancer Therapy Pipeline? - StockTitan

Feb 27, 2025
pulisher
Feb 22, 2025

Mustang Bio secures shareholder nod for warrant share issuance By Investing.com - Investing.com South Africa

Feb 22, 2025
pulisher
Feb 21, 2025

Mustang Bio secures shareholder nod for warrant share issuance - Investing.com India

Feb 21, 2025
pulisher
Feb 19, 2025

CI Financial Corp (CIX:CA): Stock Forecast and Q4 2024 Earnings Report - The Globe and Mail

Feb 19, 2025
pulisher
Feb 14, 2025

Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - Investing.com Australia

Feb 14, 2025
pulisher
Feb 13, 2025

Mustang Bio sells assets and ends lease with AbbVie - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Mustang Bio Sells Assets to AbbVie, Transfers Lease - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline By Investing.com - Investing.com South Africa

Feb 13, 2025
pulisher
Feb 12, 2025

Mustang Bio regains compliance with Nasdaq minimum bid price requirement - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times

Feb 12, 2025
pulisher
Feb 11, 2025

Mustang Bio, Inc. Regains Compliance with Nasdaq Listing Requirements Following Recent Public Offering - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Nasdaq Compliance Alert: Mustang Bio Clears Major Hurdle with $2.5M Equity Milestone - StockTitan

Feb 11, 2025
pulisher
Feb 10, 2025

Mustang Bio Closes $8 Million Public Offering - citybiz

Feb 10, 2025
pulisher
Feb 10, 2025

Mustang Bio, Inc. Completes Public Offering, Raising Approximately $8 Million for Cancer Cell Therapy Development - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

Mustang Bio (MBIO) Secures Critical $8M Financing Through Strategic Share Offering - StockTitan

Feb 10, 2025
pulisher
Feb 07, 2025

Mustang Bio sets terms for $8M public offering - MSN

Feb 07, 2025

Mustang Bio Inc Azioni (MBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):